The effect of Aspirin in prevention of pre eclampcia and its complication in women with abnormal uteirn Artery Doppler ultrasound

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138809232854N1

Enrollment

Registered

2010-04-24

Start date

2008-12-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preeclampsia. Pre-eclampsia, unspecified

Interventions

Administration of 100 mg Aspirin tablet daily.

Treatment - Drugs

Administration of 100 mg Aspirin tablet daily

Eligibility

Sex/Gender

Female

Age

15 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: pregnant women in 16-18 week with preeclampsia risk such as: vascular diseas,chronic hypertension, diabet melitus, age under 20 and more than 40 years old. Exclusion criteria: women with heart disease, liver disease, thyroid disease, chronic renal disease and peptic ulcer.

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
Delivery type. Timepoint: after delivery. Method of measurement: Documented data.;Preterm labor. Timepoint: after delivery. Method of measurement: documented data.;Neonatal Apgar score. Timepoint: 1 and 5 minute after delivery. Method of measurement: heart rate, respiratory rate, tone,skin color and grimace.;Neonatal weight. Timepoint: after delivery. Method of measurement: neonatal weight asses.;Intra uterine Growth Restriction. Timepoint: after delivery. Method of measurement: based on age and weight.	—

Measure

Time frame

Delivery type. Timepoint: after delivery. Method of measurement: Documented data.;Preterm labor. Timepoint: after delivery. Method of measurement: documented data.;Neonatal Apgar score. Timepoint: 1 and 5 minute after delivery. Method of measurement: heart rate, respiratory rate, tone,skin color and grimace.;Neonatal weight. Timepoint: after delivery. Method of measurement: neonatal weight asses.;Intra uterine Growth Restriction. Timepoint: after delivery. Method of measurement: based on age and weight.

—

Primary

Measure	Time frame
In prevention of pre eclampcia and its complication in women with abnormal uteirn Artery Doppler ultrasound. Timepoint: every two weeks. Method of measurement: patient visit and blood presure chek.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Abedzadeh kalahroudi

Kashan University of Medical Sciences

abedzadeh@kaums.ac.ir+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026